Article info
PDFEditorial
Targeting Th2-typified immune responses to prevent immunopathology in rheumatic diseases: belittled therapeutic strategies?
- Correspondence to Dr Joel A G van Roon, Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, PO Box 85500, Utrecht 3508 GA, The Netherlands; j.vanroon{at}umcutrecht.nl
Citation
Targeting Th2-typified immune responses to prevent immunopathology in rheumatic diseases: belittled therapeutic strategies?
Publication history
- Received August 27, 2013
- Revised November 12, 2013
- Accepted November 24, 2013
- First published December 9, 2013.
Online issue publication
November 02, 2019
Article Versions
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions